Publications by authors named "Mahshad Goharimehr"
Background: Diabetes mellitus, particularly Type 2 diabetes (T2D), represents a significant global health challenge, with its prevalence steadily rising over the past few decades. This study was conducted with the aim of estimating the economic burden of T2D in Iran.
Methods: This study employed a prevalence-based approach to estimate the economic burden of T2D and its attributable complications in adults above 20 years old in Iran for 2022.
Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review.
Curr Ther Res Clin Exp
September 2024
Background: With the rising burden of cardiovascular disease (CVD) and the need for cost-effective interventions, evaluating the economic implications of Evolocumab becomes crucial.
Objectives: This study aimed to systematically review and evaluate the cost-effectiveness of Evolocumab in adults at risk of CVD.
Methods: We performed an extensive search in Cochrane Library, EMBASE, PubMed, ProQuest, and Web of Science.
Article Synopsis
- This study assesses the health impact of COVID-19 in Iran using disability-adjusted life years (DALYs) based on data from the Iran Health Insurance Organization, which covers nearly half the population.
- From February 2020 to December 2021, over 1 million individuals were hospitalized due to COVID-19, with a significant burden reflecting in estimated DALYs of 665,823 in 2020 and 928,393 in 2021.
- COVID-19 emerged as the fifth leading cause of disease burden in Iran and the third major cause of death, highlighting the need for effective health policies and programs to address this ongoing issue.*